© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
May 04, 2022
Pharmacists can improve quality of life for the women they care for by offering advice, education, and other point-of-care services.
May 02, 2022
Oteseconazole (Vivjoa) reduces the incidence of recurrent vulvovaginal candidiasis.
Data from a cohort of 5000 patients indicates that NSAID use may negatively effect clodronate therapy in older women.
April 25, 2022
Between 6% and 10% of women diagnosed with vulvovaginal candidiasis are believed to develop a recurrent form of this condition with 3 to 4 or more episodes in a single year.
February 28, 2022
February 21, 2022
Ibrexafungerp is a promising novel, well-tolerated and effective oral 1-day treatment for acute vulvovaginal candidiasis.
Apetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?
February 14, 2022
While the use of combined oral contraceptives in patients with rheumatoid and autoimmune disorders have focused on safety, a recent narrative review highlighted the efficacy and benefits of these contraceptives in women with RA.
February 10, 2022
A presentation at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Pregnancy Meeting explored possible associations with marijuana use and nausea and vomiting in early pregnancy.
February 09, 2022
An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.